Hepion Pharmaceuticals Inc. (NASDAQ: HEPA) established initial surge of 3.03% at $1.70, as the Stock market unbolted on May 19, 2021. During the day, the stock rose to $1.75 and sunk to $1.59 before settling in for the price of $1.65 at the close. Taking a more long-term approach, HEPA posted a 52-week range of $1.45-$4.83.
Meanwhile, its Annual Earning per share during the time was 64.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 65.60%. This publicly-traded company’s shares outstanding now amounts to $76.23 million, simultaneously with a float of $62.65 million. The organization now has a market capitalization sitting at $127.13 million. At the time of writing, stock’s 50-day Moving Average stood at $1.8320, while the 200-day Moving Average is $2.5085.
Hepion Pharmaceuticals Inc. (HEPA) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Hepion Pharmaceuticals Inc. industry. Hepion Pharmaceuticals Inc.’s current insider ownership accounts for 0.10%, in contrast to 28.60% institutional ownership. According to the most recent insider trade that took place on Feb 18, this organization’s Chief Financial Officer bought 10,000 shares at the rate of 2.00, making the entire transaction reach 20,000 in total value, affecting insider ownership by 14,800. Preceding that transaction, on Feb 18, Company’s CEO and Director bought 20,000 for 2.00, making the whole transaction’s value amount to 40,000. This particular insider is now the holder of 45,259 in total.
Hepion Pharmaceuticals Inc. (HEPA) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 12/30/2020, it has been observed that the corporation posted -$0.29 earnings per share (EPS) during the time that was less the consensus figure (set at -$0.2) by -$0.09. This company achieved a return on equity of -71.79. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
Hepion Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 65.60% and is forecasted to reach -0.51 in the upcoming year.
Hepion Pharmaceuticals Inc. (NASDAQ: HEPA) Trading Performance Indicators
Let’s observe the current performance indicators for Hepion Pharmaceuticals Inc. (HEPA). It’s Quick Ratio in the last reported quarter now stands at 9.10. The Stock has managed to achieve an average true range (ATR) of 0.11.
In the same vein, HEPA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.54, a figure that is expected to reach -0.20 in the next quarter, and analysts are predicting that it will be -0.51 at the market close of one year from today.
Technical Analysis of Hepion Pharmaceuticals Inc. (HEPA)
Now, what If we examine the latest scores posted by [Hepion Pharmaceuticals Inc., HEPA]. During the last 5-days, its volume was lower the volume of 4.69 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 84.28% While, its Average True Range was 0.1077.
Raw Stochastic average of Hepion Pharmaceuticals Inc. (HEPA) in the period of the previous 100 days is set at 14.45%, which indicates a major fall in contrast to 71.43% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 49.74% that was lower than 92.51% volatility it exhibited in the past 100-days period.